Peter Attia· MD
alone bumpadoic acid lowers LDL about 18 percent so kind of in your range of acetamide you know a little bit more lowering if it's used as monotherapy without statins about 21 percent and Statin intolerant patients
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
alone bumpadoic acid lowers LDL about 18 percent so kind of in your range of acetamide you know a little bit more lowering if it's used as monotherapy without statins about 21 percent and Statin intolerant patients
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.